The effect of angiotensin-converting enzyme inhibition on inflammatory and angiogenic factors in hypercholesterolemia

Pharmacological Reports

Volumn 67, Issue 5, 2015, Pages 837-841

  Mahmoudabady, Maryam ^a   Kazemi, Narges ^b   Niazmand, Saeed ^a   Rezaee, Seyyed Abdolrahim ^b   Soukhtanloo, Mohammad ^b   Hosseini, Mahmoud ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hypercholesterolemia; Nitric oxide; Renin angiotensin system; VCAM 1; VEGF

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; ANGIOGENIC PROTEIN; CHOLESTEROL INTAKE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LIPID; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME INHIBITION; HYPERCHOLESTEROLEMIA; LIPID DIET; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REMISSION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ANIMAL; BLOOD; CHOLESTEROL INTAKE; METABOLISM; WISTAR RAT;

ANGIOGENIC PROTEINS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYTOKINES; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; TRIGLYCERIDES; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84939796295     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.01.008     Document Type: Article

References (35)

1. M.J. van Rooy, and E. Pretorius Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events Curr Med Chem 21 19 2014 2121 2129
2. C. Weber, and H. Noels Atherosclerosis: current pathogenesis and therapeutic options Nat Med 17 11 2011 1410 1422
3. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 7347 2011 317 325
4. M. Ratheesh, G.L. Shyni, G. Sindhu, and A. Helen Inhibitory effect of Ruta graveolens L. on oxidative damage, inflammation and aortic pathology in hypercholesteromic rats Exp Toxicol Pathol 63 3 2011 285 290
5. A. Durante, G. Peretto, A. Laricchia, F. Ancona, M. Spartera, A. Mangieri, and et al. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis Curr Pharm Des 18 7 2012 981 1004
6. H. Lu, A. Balakrishnan, D.A. Howatt, C. Wu, R. Charnigo, G. Liau, and et al. Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis Br J Pharmacol 165 6 2012 2000 2008
7. M. Kamper, O. Tsimpoukidi, A. Chatzigeorgiou, M. Lymberi, and E.F. Kamper The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats Transl Res 156 1 2010 26 36
8. K.M. Botham, and C.P. Wheeler-Jones Postprandial lipoproteins and the molecular regulation of vascular homeostasis Prog Lipid Res 52 4 2013 446 464
9. S. Haghjooyjavanmard, M. Nematbakhsh, and M. Soleimani The effect of hypercholesterolemia on serum vascular endothelial growth factor and nitrite concentrations in early stage of atherosclerosis in rabbits Pak J Nutr 8 1 2009 86 89
10. M. Sata, and D. Fukuda Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis J Med Invest 57 1-2 2010 12 25
11. S. Matsumoto, M. Shimabukuro, D. Fukuda, T. Soeki, K. Yamakawa, H. Masuzaki, and et al. Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice Cardiovasc Diabetol 13 2014 30
12. U. Forstermann Nitric oxide and oxidative stress in vascular disease Pflugers Arch 459 6 2010 923 939
13. V. Conti, G. Russomanno, G. Corbi, V. Izzo, C. Vecchione, and A. Filippelli Adrenoreceptors and nitric oxide in the cardiovascular system Front Physiol 4 2013 321
14. V. Papademetriou Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events Am Heart J 157 6 Suppl. 2009 S24 S30
15. Y. Hong, S.C. Hui, T.Y. Chan, and J.Y. Hou Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats Am J Chin Med 30 4 2002 589 599
16. M. Miguel, R. Lopez-Fandino, M. Ramos, and A. Aleixandre Short-term effect of egg-white hydrolysate products on the arterial blood pressure of hypertensive rats Br J Nutr 94 5 2005 731 737
17. X.C. Shen, and Z.Y. Qian Effects of crocetin on antioxidant enzymatic activities in cardiac hypertrophy induced by norepinephrine in rats Pharmazie 61 4 2006 348 352
18. V. Bassaneze, V.G. Barauna, C. Lavini-Ramos, J. Kalil, I.T. Schettert, A.A. Miyakawa, and et al. Shear stress induces nitric oxide-mediated vascular endothelial growth factor production in human adipose tissue mesenchymal stem cells Stem Cells Dev 19 3 2010 371 378
19. S. Peters Inhibition of atherosclerosis by angiotensin II type 1 receptor antagonists Am J Cardiovasc Drugs 13 4 2013 221 224
20. J. Abd Alla, A. Langer, S.S. Elzahwy, G. Arman-Kalcek, T. Streichert, and U. Quitterer Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis J Biol Chem 285 30 2010 23496 23505
21. J.R. Priestley, M.W. Buelow, S.T. McEwen, B.D. Weinberg, M. Delaney, S.F. Balus, and et al. Reduced angiotensin II levels cause generalized vascular dysfunction via oxidant stress in hamster cheek pouch arterioles Microvasc Res 89 2013 134 145
22. S. Xu, S. Ogura, J. Chen, P.J. Little, J. Moss, and P. Liu LOX-1 in atherosclerosis: biological functions and pharmacological modifiers Cell Mol Life Sci 70 16 2013 2859 2872
23. T. Imanishi, H. Ikejima, H. Tsujioka, A. Kuroi, K. Kobayashi, Y. Muragaki, and et al. Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability Hypertension 51 3 2008 734 741
24. S.E. Heinonen, A.M. Kivela, J. Huusko, M.H. Dijkstra, E. Gurzeler, P.I. Makinen, and et al. The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models Cardiovasc Res 99 4 2013 716 723
25. Z. Zheng, H. Chen, G. Ke, Y. Fan, H. Zou, X. Sun, and et al. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway Diabetes 58 4 2009 954 964
26. A.J. Flammer, I. Sudano, F. Hermann, S. Gay, A. Forster, M. Neidhart, and et al. Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis Circulation 117 17 2008 2262 2269
27. Y.J. Lee, D.H. Choi, E.J. Kim, H.Y. Kim, T.O. Kwon, D.G. Kang, and et al. Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet Am J Chin Med 39 1 2011 39 52
28. J. Rathouska, I. Nemeckova, L. Zemankova, Z. Strasky, K. Jezkova, M. Varejckova, and et al. Cell adhesion molecules and eNOS expression in aorta of normocholesterolemic mice with different predispositions to atherosclerosis Heart Vessels 2014 1 8
29. H.L. Lin, H.W. Yen, S.L. Hsieh, L.M. An, and K.P. Shen Low-dose aspirin ameliorated hyperlipidemia, adhesion molecule, and chemokine production induced by high-fat diet in Sprague-Dawley rats Drug Dev Res 75 2 2014 97 106
30. F. Zhang, J. Ren, K. Chan, and H. Chen Angiotensin-(1-7) regulates angiotensin II-induced VCAM-1 expression on vascular endothelial cells Biochem Biophys Res Commun 430 2 2013 642 646
31. H. Tsuneki, E. Tokai, T. Suzuki, T. Seki, K. Okubo, T. Wada, and et al. Protective effects of coenzyme Q10 against angiotensin II-induced oxidative stress in human umbilical vein endothelial cells Eur J Pharmacol 701 1-3 2013 218 227
32. F. Montecucco, A. Pende, and F. Mach The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies Mediat Inflamm 2009 2009 752406
33. Y. Lu, X. Zhu, G.X. Liang, R.R. Cui, Y. Liu, S.S. Wu, and et al. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-kappaB/JNK signal pathway in human umbilical vein endothelial cells Amino Acids 43 5 2012 2125 2136
34. S.H. Yan, N.W. Zhao, X.X. Zhu, Q. Wang, H.D. Wang, R. Fu, and et al. Benazepril inhibited the NF-kappaB and TGF-beta networking on LV hypertrophy in rats Immunol Lett 152 2 2013 126 134
35. A.F. Pasini, U. Garbin, M.C. Nava, C. Stranieri, M. Pellegrini, V. Boccioletti, and et al. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients Am J Hypertens 20 4 2007 443 450